UCSB News Release on the presentation of the first results of the KETO-ADPKD clinical trial at the American Society for Nephrology annual conference.

Congratulations to all co-authors!
Our latest paper was just published in PNAS, titled "Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression."

By Sonia Fernandez

Tuesday, May 17, 2022 - 14:45

Santa Barbara, CA

UC Santa Barbara molecular biologist Thomas Weimbs, left, recently welcomed Glenn Frommer, right, to the campus as the latter whizzed through Santa Barbara on a 5,300 mile Ride for PKD. The Weimbs Lab was one of the stops on this ambitious bicycle odyssey to raise awareness and research funding to find a treatment for polycystic kidney disease, which affects 600,000 Americans and more than 12.4 million people globally.

This was a collaboration with a research group in Thailand. Congratulations to all the authors.